Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or backend; the visible study details and layout remain unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. This indicates a platform update and does not alter the study information presented on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedEnrollment status was updated to indicate no further participant recruitment. The page additionally adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment heading, including a Revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check41 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a small patch to the page without altering the visible study details.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new version of the page. It reflects minor maintenance or enhancements to the page's content or underlying code.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform or release change rather than an update to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.